InnoCan Pharma (INNPF)
OTHER OTC:INNPF
Holding INNPF?
Track your performance easily

InnoCan Pharma (INNPF) Financial Statements

11 Followers

InnoCan Pharma Financial Overview

InnoCan Pharma's market cap is currently ―. The company's EPS TTM is $-0.016; its P/E ratio is -5.45; InnoCan Pharma is scheduled to report earnings on November 27, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total Revenue$ 6.77M$ 4.89M$ 4.08M$ 3.12M$ 1.56M
Gross Profit$ 6.00M$ 4.29M$ 3.66M$ 2.66M$ 1.37M
EBIT$ -1.17M$ -588.00K$ -1.21M$ -395.00K$ -1.23M
EBITDA$ -1.16M$ -580.00K$ -1.20M$ -386.00K$ -1.22M
Net Income Common Stockholders$ -1.77M$ -883.00K$ -2.03M$ -520.00K$ -1.27M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 4.59M$ 3.88M$ 4.02M$ 3.37M$ 4.09M
Total Assets$ 9.04M$ 6.94M$ 6.87M$ 5.90M$ 6.40M
Total Debt$ 7.00K$ 33.00K$ 16.00K$ 26.00K$ 26.00K
Net Debt$ -4.59M$ -3.85M$ -4.01M$ -3.35M$ -4.06M
Total Liabilities$ 4.33M$ 2.55M$ 2.37M$ 899.00K$ 1.06M
Stockholders Equity$ 4.11M$ 4.10M$ 4.30M$ 5.01M$ 5.47M
Cash Flow-
Free Cash Flow$ -749.00K$ -1.32M$ -719.00K$ -722.00K$ -1.19M
Operating Cash Flow$ -747.00K$ -1.31M$ -718.00K$ -713.00K$ -1.16M
Investing Cash Flow$ -2.00K$ -9.00K$ -32.00K$ -9.00K$ -34.00K
Financing Cash Flow$ 1.45M$ 1.12M$ 1.45M$ -6.00K$ 357.00K
Currency in USD

InnoCan Pharma Earnings and Revenue History

InnoCan Pharma Debt to Assets

InnoCan Pharma Cash Flow

InnoCan Pharma Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis